APA (7th ed.) Citation

Corrie, P. G., Qian, W., Basu, B., Valle, J. W., Falk, S., lwuji, C., . . . Bax, L. (2020). Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma. British Journal of Cancer, 122(12), 1760. https://doi.org/10.1038/s41416-020-0846-2

Chicago Style (17th ed.) Citation

Corrie, P. G., et al. "Scheduling Nab-paclitaxel Combined with Gemcitabine as First-line Treatment for Metastatic Pancreatic Adenocarcinoma." British Journal of Cancer 122, no. 12 (2020): 1760. https://doi.org/10.1038/s41416-020-0846-2.

MLA (9th ed.) Citation

Corrie, P. G., et al. "Scheduling Nab-paclitaxel Combined with Gemcitabine as First-line Treatment for Metastatic Pancreatic Adenocarcinoma." British Journal of Cancer, vol. 122, no. 12, 2020, p. 1760, https://doi.org/10.1038/s41416-020-0846-2.